Drug Development (oncology, cancer)

Drug Development (oncology, cancer)

a subgroup of ECCO – The European CanCer Organisation

70 members
  • Join

    When you join a group, other members will be able to see your profile and message you. The group logo will be visible on your profile unless you change that setting.

Group Profile

Private group. To request membership, click Join and your request will be reviewed by the group manager.

Drug development is a blanket term used to define the entire process of bringing a new drug or device to the market. A drug is a well defined molecule obtained by synthesis according to the usual processes of chemistry, or by recombinant DNA technique, which is particularly adapted to the polypeptide molecules. All stages from drug discovery/product development, pre-clinical research (microorganisms/animals) to clinical trials (on humans) etc. can be discussed here in order to advance the treatment of cancer patients.

http://www.ecco-org.eu/Conferences-and-Events/2011-Stockholm-Congress/page.aspx/217

About this Subgroup

  • Created: June 1, 2011
  • Type: Conference Group
  • Members: 70
  • Subgroups: 4